<DOC>
	<DOCNO>NCT01196468</DOCNO>
	<brief_summary>In Europe many patient infected HIV remain undiagnosed , although percentage varies 15-80 % across continent . In UK estimate 27 % . Undiagnosed HIV result increase morbidity mortality reduce treatment response , appropriate health intervention delay . It also adverse public health implication , individual unaware HIV status likely transmit virus . An important public health issue diagnose individual HIV early course infection . In US , Centre Disease Control Prevention ( CDC ) introduce test guideline whereby individual test , unless object , point contact healthcare system - `` opt-out '' test guideline . At `` HIV Europe '' Conference hold November 2007 , consensus , include patient public involvement , approach would suitable Europe . The Conference recommend development focus HIV test patient present certain clinical condition diseases - `` indicator disease '' test guideline . Cost effectiveness analysis suggest cost saving screen population HIV prevalence least 1 % , although rate may low 0.1 % . However , little - - evidence regard HIV prevalence certain condition disease specific easy identify section society . The focus attention condition diseases occur frequently individual know infected HIV . The aim study ass HIV prevalence several disease condition , within specific segment population yet diagnose HIV , present care specific disease condition . These condition select occur frequently individual already diagnose HIV infection . This pilot study inform phase two , involve disease condition wider participation centre across Europe .</brief_summary>
	<brief_title>HIV Indicator Diseases Survey Across Europe - UK Arm</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion Aged 16 year Presenting care one indicator diseases condition : A sexually transmitted disease Malignant lymphoma Cervical anal dysplasia cancer Unexplained leukocytopenia thrombocytopenia last least 4 week , hypergammaglobulinaemia Seborrheic dermatitis exanthema substudy consent provide additional information Exclusion criterion Known HIV positive substudy decline consent additional information collect</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>HIV</keyword>
	<keyword>Testing</keyword>
	<keyword>Targeted</keyword>
	<keyword>Indicator</keyword>
	<keyword>Diseases</keyword>
	<keyword>Anal dysplasia</keyword>
	<keyword>Cervical dysplasia</keyword>
	<keyword>STI</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Seborrhoeic dermatitis</keyword>
	<keyword>Exanthema</keyword>
	<keyword>Thrombocytpaenia</keyword>
	<keyword>Lymphopaenia</keyword>
	<keyword>Hypergammaglobulinaemia</keyword>
</DOC>